'Unique experience with wealthy candidates': Why Bloomberg will have a tough time in California

GE’s Top Wall Street Critic Upgrades, Says ‘We Were Wrong’

(Bloomberg) -- General Electric Co. is gaining some favor over its top skeptic in Wall Street, who cited a better-than-expected performance last year.JPMorgan’s Stephen Tusa upgraded the shares to neutral from a sell-equivalent rating, citing 2019’s free cash flow that topped his predictions as well as an improved outlook for 2020. The analyst has held an underweight stance on the stock since April.“We were wrong,” Tusa said, noting that GE shares have outperformed the sector by 11% since that call.GE is big enough that it has many options to boost near-term cash in a given period even as there are still questions about the true value of the underlying businesses. That makes it tough to be a bear in the stock. “As we have seen in some instances, the advance on orders is worth more than the revenue booked over time,” he said.Yet his new price target of $8, up from...

Billionaire Steve Cohen Snaps Up These 3 High-Yield Dividend Stocks

Markets have been nosediving in recent sessions, as the coronavirus scare spreads. While public health professionals are trying to cope with the spread, and to educate the public, the economic effects are real. Quarantines and travel restrictions have impacted airlines, shipping companies, and factories. Demand for oil is down, pushing down prices and hurting energy stocks. Tech companies, especially those with supply chains based in China, are feeling the pain as well.But in the markets, what goes down will (usually) come back up. Low prices may hurt right now, but they are also an opportunity – to buy in. A savvy investor can find deals now, on stocks with high potential and real return value. Dividend stocks are clear choice for investors looking to buy in. On one level, their appeal is obvious – a reliable, high yield dividend represents a steady income stream even when markets turn south. But there...

Co-Diagnostics To Provide Coronavirus Tests To Certified US Labs After FDA Policy Change

Co-Diagnostics, Inc. (NASDAQ: CODX) shares were trading higher Monday after the company announced it will provide COVID-19 tests to U.S. Clinical Laboratory Improvement Amendments, or CLIA, labs.Co-Diagnostics is a molecular diagnostics company with a patented platform for the development of diagnostic tests.The CLIA regulate laboratory testing and require clinical laboratories to be certified by their state as well as the Center for Medicare and Medicaid Services before they can accept human samples for diagnostic testing.Following a recent change to the Food and Drug Administration's policy toward the coronavirus outbreak, the company's coronavirus test kits are now available to laboratories certified under the CLIA for use according to the FDA guidelines, Co-Diagnostics said in a press release. Co-Diagnostics said it is in discussions with qualified CLIA laboratories that can use COVID-19 tests built on Co-Diagnostics' platform technology in their emergency use authorization submissions with the FDA."We believe this change will allow the...

Walmart Requests Payout Delay In Sleeper Berth Case

Walmart Inc. has asked the U.S. Court of Appeals for the 9th Circuit to hold off on requiring the company to pay a $60.8 million judgement to approximately 800 drivers until Walmart decides whether it will appeal to the U.S. Supreme Court — and the high court decides whether to hear the case.Last week the 9th Circuit denied a petition by Walmart Inc (NYSE: WMT) to rehear the case after the appeals court had upheld a lower court's decision in which a jury awarded $54.6 million — plus an additional $6.2 million in restitution awarded by the court — to former California truck drivers for time spent in sleeper berths during layovers between trips.Walmart said in a Thursday filing with the appeals court that it is obligated to pay an additional $12.9 million in fees and $1.5 million in other costs."Walmart will be harmed absent a stay because it will likely be...